Risk USA: Margin for OTC products is too high, says Pimco's De Leon

Healthy options

Incoming margin regimes for over-the-counter derivatives are too high, while those for the futures market may be too low, according to William De Leon, global head of portfolio risk management at Pimco - and the too-high OTC margin requirements could distort markets for eligible collateral.

The issue hinges on assumptions about how long it will take a central counterparty (CCP) to liquidate the portfolio of a defaulted member or client. That assumption drives the amount of initial margin a

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

If you already have an account, please sign in here.

Register

Want to know what’s included in our free membership? Click here

This address will be used to create your account

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: